Korean drug makers shy of M&As

The government plans to ease regulations to promote the development of innovative medicine and medical treatments, as well as encourage mergers and acquisitions (M&As) among pharmaceutical firms in order to make them more productive and profitable.

Under the plan, the government hopes to reduce the number of the current 240 GMP-endorsed pharmaceutical firms to 100 through the massive price-c...